Piretanide

Piretanide

SCHEMBL18075706

NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1.O=S(=O)(O)O

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Piretanide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.95
▸ HSD17B10 Q99714 4/20 0.95
▸ ALDH1A1 P00352 3/20 0.95
▸ HPGD P15428 3/20 0.95
▸ LMNA P02545 3/20 0.95
▸ USP2 O75604 2/20 0.95
▸ HIF1A Q16665 2/20 0.95
▸ SLC6A4 P31645 1/20 0.95
▸ TSHR P16473 2/20 0.50
▸ CA2 P00918 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ SLC12A2 P55011 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ ERAP1 Q9NZ08 2/20 0.41
▸ ERAP2 Q6P179 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ GAA P10253 3/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MMP2 P08253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piretanide SCHEMBL30230376 0.98 KDM4E (1.00) KDM4EHSD17B10ALDH1A1HPGDLMNA
Piretanide SCHEMBL1741994 0.98 KDM4E (1.00) KDM4EHSD17B10ALDH1A1HPGDLMNA
Piretanide SCHEMBL49473 0.98 KDM4E (1.00) KDM4EHSD17B10ALDH1A1HPGDLMNA
Piretanide SCHEMBL9837127 0.97 KDM4E (0.98) KDM4EHSD17B10ALDH1A1HPGDLMNA
SCHEMBL2741891 0.97 KDM4E (0.98) KDM4EHSD17B10ALDH1A1HPGDLMNA
Piretanide SCHEMBL7895002 0.95 KDM4E (0.95) KDM4EHSD17B10ALDH1A1HPGDLMNA
SCHEMBL11542770 0.95 KDM4E (0.95) KDM4EHSD17B10ALDH1A1HPGDLMNA
SCHEMBL11546942 0.93 LMNA (0.91) KDM4EHSD17B10ALDH1A1HPGDLMNA
SCHEMBL231996 0.90 ALDH1A1 (0.85) KDM4EHSD17B10ALDH1A1HPGDLMNA
Piretanide SCHEMBL250849 0.90 KDM4E (0.84) KDM4EHSD17B10ALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180052161-A1 BIOMARKERS FOR MALARIA DIAGNOSIS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2018-02-22 — — US disclosed
WO-2016149386-A1 BIOMARKERS FOR MALARIA DIAGNOSIS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2016-09-22 — — WO disclosed
Send feedback